Product Introduction
Product Name: Eptifibatide Acetate
Product Purity: ≥98% (Research Grade)
CAS No: 148031-34-9
Testing Method: HPLC (High Performance Liquid Chromatography)
Active Ingredient: Eptifibatide Acetate (a cyclic heptapeptide)
Product Characteristics: White to off-white powder
Product Mesh: 80-120 mesh
Product Use: Only for laboratory-level cardiovascular pharmacology research, platelet function research, and drug development-related studies (not for human/animal use)
Storage Conditions: Vacuum freeze-dried storage at -20°C (strictly prohibited from repeated freeze-thaw cycles)
Shelf Life: 24-36 months (unopened, specific period as indicated on packaging)
Product Description & Research Information
Shaanxi Sunrise Pharmaceutical Co., Ltd. specializes in producing high-purity Eptifibatide Acetate research-grade reagent, synthesized using advanced technology with a stable purity of ≥98.0% (HPLC). We strictly follow cGMP standards for research reagents to implement full-process quality control, ensuring exceptional batch-to-batch consistency and low impurity levels.
Eptifibatide Acetate is a synthetic cyclic heptapeptide known to be a highly selective antagonist of the platelet GPIIb/IIIa receptor in research models. This makes it a valuable tool compound for investigating platelet aggregation mechanisms and for use in pre-clinical studies related to thrombotic disorders in the laboratory.
Research-Oriented Mechanism of Action Reference
The following information is derived from public academic literature, only for laboratory research background reference:
GPIIb/IIIa Receptor Antagonism: In in vitro platelet studies, Eptifibatide Acetate reversibly blocks the binding of fibrinogen to the GPIIb/IIIa receptor complex.
Inhibition of Platelet Aggregation: By blocking the final common pathway of platelet aggregation, this compound inhibits thrombus formation in research models.
Research Application Scenarios (Laboratory Only)
| Research Direction | Research Value Reference |
|---|---|
| Platelet Biology & Pharmacology | Study GPIIb/IIIa receptor ligands and signaling pathways involved in platelet activation in vitro. |
| Thrombosis & Hemostasis Research | Investigate the role of platelet aggregation in various thrombotic models using in vitro assays. |
| Cardiovascular Drug Discovery | Use as a positive control in screening campaigns for novel anti-platelet or anti-thrombotic agents. |
Core Advantages
High Purity & Quality: ≥98.0% (HPLC verified) for reliable platelet function and receptor binding assays.
Well-Characterized Tool Compound: A widely cited selective GPIIb/IIIa antagonist in cardiovascular research literature.
Synthetic Peptide Advantages: No inherent immunogenicity, crucial for in vitro and ex vivo pharmacology studies.
Stability & Long Shelf-Life: 24-36 months shelf life when stored correctly (-20°C).
Comprehensive Documentation: Detailed Certificate of Analysis (COA) provided for traceability.
FAQ (For Research Use Only)
Q1: How to obtain the COA quality inspection report for Eptifibatide Acetate?
A: Contact our customer service with your order number to obtain the electronic COA, or verify it through our official website's portal.
Q2: Does this GPIIb/IIIa antagonist support customization?
A: Yes, we offer customization for purity, packaging, and dosage. Contact customer service for details; customized products also include a COA.
Q3: What are the procurement subject requirements for research reagents?
A: Only supplied to legal research institutions (pharmaceutical R&D companies, biotech labs, universities). Individuals are not eligible. Qualification documents are required.
Q4: Why is Eptifibatide Acetate valuable in cardiovascular research?
A: As a highly selective GPIIb/IIIa receptor antagonist, it is an ideal tool for studying platelet function, investigating thrombotic mechanisms, and screening for new anti-platelet drugs in laboratory settings.